Advertisement
U.S. markets open in 4 hours 55 minutes

Valeo Pharma Inc. (VPHIF)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
0.04690.0000 (0.00%)
At close: 03:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.0000
Open0.1181
Bid0.0295 x 0
Ask0.0342 x 0
Day's Range0.1181 - 0.1181
52 Week Range0.0343 - 0.2540
Volume4,500
Avg. Volume12
Market Cap4.627M
Beta (5Y Monthly)1.60
PE Ratio (TTM)N/A
EPS (TTM)-0.2600
Earnings DateJan 27, 2025 - Jan 31, 2025
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    VALEO PHARMA INITIATES RESTRUCTURING PROCEEDINGS UNDER THE CCAA TO IMPLEMENT A REVIEW OF ITS STRATEGIC ALTERNATIVES

    Valeo Pharma Inc. (TSX: VPH) (FSE: VP2), a Canadian pharmaceutical company, announced today that the Québec Superior Court (Commercial Division) (the "Court") has issued an initial order (the "Initial Order") granting the Company and its subsidiaries VPI Pharmaceuticals Inc. / VPI Pharmaceutiques Inc. and Valeo Pharma Corp. (collectively, the "Company" or "Valeo") protection under the Companies' Creditors Arrangement Act (R.S.C., 1985, c. C-36) (the "CCAA").

  • CNW Group

    VALEO PHARMA REPORTS THIRD QUARTER 2024 REVENUES

    Valeo Pharma Inc. (TSX: VPH) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today reported its financial results for the third quarter ended July 31, 2024.